Zacks Investment Research on MSN
TG Therapeutics (TGTX) to report Q1 results: Wall Street expects earnings growth
TG Therapeutics (TGTX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports ...
TG Therapeutics refinanced an old $250 million facility and drew a new five-year, $750 million term loan. They drew upon the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results